Form CORRESP - Correspondence:
SEC Accession No. 0001171843-22-000275
Filing Date
2022-01-14
Accepted
2022-01-14 12:03:17
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 12768
2 GRAPHIC hdr1.jpg GRAPHIC 6164
3 GRAPHIC hdr2.jpg GRAPHIC 2098
4 GRAPHIC ftr.jpg GRAPHIC 8387
  Complete submission text file 0001171843-22-000275.txt   36942
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)